Screening for brain metastases in patients with stage III non-small cell lung cancer: Is there additive value of magnetic resonance imaging above a contrast-enhanced computed tomography of the brain?

Lizza E. L. \ Hendriks, Gerben P. Bootsma, Dirk K. M. de Ruysscher, Nicole A. M. Scheppers, Paul A. M. Hofmane, Boudewijn T. Brans, Anne-Marie C. Dingemans

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)293-297
JournalLung Cancer
Volume80
Issue number3
DOIs
Publication statusPublished - Jun 2013

Keywords

  • Non small cell lung cancer
  • Magnetic resonance imaging
  • Computed tomography
  • Staging
  • (18)FDG-PET
  • Brain metastases

Cite this